WASHINGTON, DC – Mark Leahey, President and CEO of the Medical Device Manufacturers Association (MDMA), issued the following statement today regarding the Internal Revenue Service’s final rule for implementation of the 2.3% medical device excise tax:
“This final rule does nothing to prevent the loss of jobs and innovation that has already occurred as a result of the medical device tax, and will unfortunately continue if we do not repeal this bad policy...
Washington, D.C. – A broad coalition of medical technology companies, physician groups, venture capital firms and leading associations today submitted a letter to Senate leadership urging policymakers to repeal the onerous medical device tax that threatens U.S. jobs, medical innovation and patient care. The Medical Device Manufacturers Association (MDMA), ...
MDMA hosted a member-wide webinar this week to analyze the election results and what it will mean for the regulatory environment, reimbursement and more.
"The election results make it clear that Americans want bipartisan solutions to the challenges confronting our economy, and that elected officials should remove barriers to innovation and job creation," said Mark Leahey, President and CEO of MDMA. "Repealing the medical device tax is a perfect example where...
As policy makers continue to examine the best methods for controlling the costs of health care, one of the lead supporters of comparative effectiveness research (CER) is voicing concerns that the Patient Centered Outcomes Research Institute (PCORI) is lacking the sense of urgency to tackle high-impact clinical questions.
In an article published in Health Affairs, Harold Sox, who co-chaired the 2009 Institute of Medicine panel on CER, argued that due to the slow...
New research shows that despite providing near-universal health care coverage in the state of Massachusetts, the overwhelming percentage of medical device companies saw no increases in utilization, and in turn profits. This new data helps debunk the main argument for supporters of the 2.3 % medical device excise tax.
The report was detailed in a Congressional briefing hosted by CONNECT.
Alex Lukianov, MDMA Board member and Chairman & Chief...
Hearings in the U.S. House and Senate this week displayed bipartisan frustration with the IRS, CMS and other agencies that are responsible for issuing rules and regulations on implementation of the Affordable Care Act.
The Senate Aging Committee held a hearing entitled "Parting the Clouds: Implementing the Physician Payments Sunshine Act," and Senators expressed frustration that CMS had yet to issue final rules regarding the legislation.
"Many companies have...
A report issued this week by the Institute of Medicine (IOM) detailed billions of dollars of wasteful spending in the nation's health care system. The report has already garnered much attention from policy makers and the media, and is expected to play a pivotal role in the ongoing discussions on how to reduce costs in the delivery of care.
According to the report, there was $750 billion in wasted health care spending in 2009. It described the waste as...
WASHINGTON, DC – Mark Leahey, President and CEO of the Medical Device Manufacturers Association (MDMA), issued the following statement today regarding the U.S. Supreme Court’s decision on the “Affordable Care Act” (ACA):
“Today’s decision adds new urgency to repealing the medical device tax so that patients and providers can continue to expect innovative devices and technologies. While MDMA and our members still have seen no evidence...
WASHINGTON, DC – Mark Leahey, President and CEO of the Medical Device Manufacturers Association (MDMA), issued the following statement today regarding bipartisan passage of H.R. 436, the “Health Care Cost Reduction Act of 2012,” which includes repeal of the 2.3% medical device tax, in the U.S. House of Representatives:
“MDMA applauds the House passage of legislation to repeal the medical device tax, and we urge the Senate to act on this important...
WASHINGTON, DC -- A broad coalition of medical technology companies and leading associations wrote to Congressional leaders today urging them to repeal the onerous medical device tax which will destroy jobs and harm innovation. The letter had more than 700 signatories, including the Medical Device Manufacturers Association (MDMA), the Advanced Medical Technology Association (AdvaMed), the Medical Imaging & Technology Alliance (MITA), the U.S. Chamber of Commerce,...
